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Apoptosis, also known as programmed cell death, is a cellular process used for 
development or for when cells undergo injury or stress. The Bcl2 family of proteins 
includes both pro-apoptotic and anti-apoptotic proteins that control the intrinsic pathway 
of apoptosis. Understanding the mechanisms and influence these proteins have on 
apoptosis is an important area of research focused on in Dr. Jones’s lab. Evidence shows 
a homology amongst the Bcl2 family of proteins at the BH3 domain. Dr. Jekabsons' lab 
has found a potential homology amongst VDAC 1-3 and the Bcl2 family at the BH3 
domain.  
Specifically, our lab is using Drosophila melanogaster to test the interaction 
between VDACs and Bax by mutating the Drosophila’s VDAC. We are interested in 
discovering if mutation of this domain causes a phenotypic change in the Drosophila 
melanogaster, and if the change is harmful or beneficial. We constructed transgenic 
plasmids using a pUBI-ATTB plasmid as a vector and mouse VDAC cDNA as our gene 
of interest. We hypothesize that Bax and VDAC interact to prevent the premature 
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BACKGROUND AND INTRODUCTION  
1.1: Intrinsic Apoptotic Pathway   
Apoptosis is a method of programmed cell death, mainly when cells initiate an 
intracellular death program, killing themselves in a controlled manner (Alberts, et al., 
2008). Apoptosis is used for development or for when cells undergo injury or stress 
(Alberts, et al., 2008). This process takes place in the mitochondria, and the Bcl2 family 
of proteins is the major regulator in vertebrates (Alberts, et al., 2008). Apoptotic 
intracellular activation happens by the intrinsic pathway of apoptosis (Alberts, et al., 
2008). The pathway operates by regulating the release of cytochrome c in the cytosol 
(Alberts, et al., 2008). 
The Bcl2 family includes both pro-apoptotic and anti-apoptotic proteins (Figure 
1). Pro-apoptotic proteins, such as BH123 and BH3-only, initiate apoptosis by promoting 
the release of cytochrome c (Alberts, et al., 2008). On the other hand, anti-apoptotic 
proteins, such as the Bcl2 protein, inhibit apoptosis by preventing the release of 
cytochrome c (Alberts, et al., 2008). There are four unique Bcl2 homology domains BH1, 
BH2, BH3, and BH4 (Figure 1). BH3-only proteins are different from Bcl2, except for 
their shared sequence homology at the BH3 domain (Figure 1). Also, BH3-only proteins 
initiate apoptosis primarily by inhibiting anti-apoptotic Bcl2 proteins (Alberts, et al., 
2008). The anti-apoptotic Bcl2 proteins are found on the cytosolic surface of the 
mitochondrial outer membrane (MOM). They assist in maintaining the integrity of the
2 
membrane (Alberts, et al., 2008). These proteins inhibit apoptosis by binding to and 
hindering the pro-apoptotic Bcl2 proteins (Alberts, et al., 2008). 
 
Figure 1: The three classes of the Bcl2 family of proteins. The BH3 domain in purple 
can be observed as the only domain that is shared by all classes of Bcl2-like proteins 
(Adapted from Alberts, et al., 2008).  
 
1.2: Bax/Bak regulation with Bcl2 like proteins   
BH123 proteins, including Bax and Bak, have similar homologies to Bcl2, except 
for the BH4 domain (Alberts, et al., 2008). When an apoptotic stimulus initiates the 
intrinsic pathway, BH123 proteins are activated and aggregate to form oligomers in the 
MOM (Figure 2). This process causes cytochrome C and other proteins to release into the 
cytosol (Figure 2). The exact mechanism of this release remains unclear. Bax can be 
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found in the cytosol and travels to the mitochondria once activated by an apoptotic 
stimulus (Alberts, et al., 2008). Alternatively, Bak remains tightly bound to the MOM, 
with or without an apoptotic stimulus present (Alberts, et al., 2008). BH3-only proteins 
are produced or activated in response to an apoptotic stimulus, and these proteins trigger 
Bax/Bak oligomers and activation of cytochrome c release. (Alberts, et al., 2008). The 
BH3 domains of the BH123 proteins bind to a hydrophobic groove on anti-apoptotic Bcl2 
proteins (Alberts, et al., 2008). This binding sequesters Bax/Bak in an inactive state with 
the anti-apoptotic protein and prevents them from forming oligomers (Alberts, et al., 
2008). 
 
Figure 2: BH3-only and anti-apoptotic Bcl2 proteins regulate intrinsic pathway. 
BH3-only proteins are activated by an apoptotic stimulus and bind to the anti-apoptotic 
Bcl2 proteins. These proteins are no longer able to inhibit BH123 proteins, allowing 
cytochrome c and other intermembrane proteins to release into the cytosol (Adapted from 
Alberts, et al., 2008)
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1.3: Bax/Bak regulation with VDAC 
As previously discussed, Bax and Bak are mainly regulated by BH3-only and 
anti-apoptotic Bcl2 proteins. A voltage-dependent anion channel (VDAC) is a pore 
forming channel protein found on the MOM. This protein is believed to now play a role 
in regulating apoptosis as well (Jekabsons and Jones, 2019). VDAC creates a channel for 
small metabolites such as ATP to exchange between the intermembrane space and the 
cytosol of the mitochondria (Jekabsons and Jones, 2019). Evidence from Dr. Jekabsons' 
lab shows a homology amongst the Bcl2 family of proteins at the BH3 domain. A 
sequence conservation at this domain has been discovered, as seen by the conserved 
aspartate in red (Figure 3).  
 
Figure 3: Sequence alignment of mouse BH3 domains of Bcl2 family members. 
VDAC 1-3 sequences can also be found to demonstrate the homology. The conserved 
aspartate is highlighted in red (Adapted from Jekabsons and Jones, 2019). 
 
In addition to discovering the sequence homology amongst the Bcl2-family 
members and VDAC1-3, members of the lab also found protein similarities when using a 
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computer model to created 3D models of the Bax protein (Figure 4). The models 
constructed demonstrate that the Bid BH3 domain and the VDAC1 BH3 domain both fit 
similarly into the hydrophobic groove of Bax, providing further evidence that VDAC 
could be related to the Bcl2 family of proteins (Figure 4).  
 
Figure 4: Bid and VDAC1 attached to Bax hydrophobic groove. Bax protein with α  
9 deleted is blue. The Bid peptide is yellow on the left, and the VDAC1 N-terminus is 
pink on the right. The residues important for binding are labeled (Adapted from 
Jekabsons and Jones, 2019). 
 
Dr. Jones’ lab proposes to use Drosophila melanogaster to test the interaction 
between VDACs and Bax by mutating the Drosophila’s VDAC. I plan to construct DNA 
plasmids containing mouse VDAC2 and Bax cDNAs to enable the construction of 
transgenic lines in Drosophila melanogaster. These lines will be used to test for genetic 
interactions between VDAC2 and Bax. The goal of our experiments is to determine if 
VDAC genetically influences Bax functions in Drosophila melanogaster. We 
hypothesize that Bax and VDAC interact to
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prevent the premature assembly of Bax pores in the mitochondrial membrane. Inducing 
Bax expression in the eyes and wings of Drosophila melanogaster causes a change in the 
wild-type phenotypes (Figure 5). Our lab is taking plasmids containing mouse VDAC 1 
and 2 and injecting them into flies to generate transgenic lines, having them expressed 
highly under control of the ubiquitin promoter, and seeing if the flies with mouse VDAC 
can influence these wild-type phenotypes induced by Bax expression.  
 
Figure 5: Altered eye and wing phenotypes with induced Bax expression. (A) +; 
UAS-Bax shows an eye exhibiting wild-type morphology from not expressing Bax due to 
lack of GAL4; a regular arrangement of ommatidia and bristles are shown. (B) GMR- 
Gal4; UAS-Bax expresses Bax in the eye; this crossing causes a disarray of ommatidia 
and bristles. (C) +; UAS-Bax shows normal wing morphology, and (D) vg-Gal4/UAS-Bax 
shows wings are nearly absent in vg-Gal4/UAS-Bax(2) flies, in which the wing imaginal 







CHAPTER II:  
MATERIALS AND METHODS  
2.1: Restriction Digest of Plasmid DNA  
 Restriction digests were performed to check the identity of plasmids as well as for 
restriction cloning. Restriction enzymes were used to cut segments of DNA at specific 
restriction sites. The digests were carried out using liquid DNA of different plasmids 
vectors and DNA inserts, appropriate restriction enzymes, as well as a restriction digest 
buffer. The buffer used in these restriction digests was the CutSmart Buffer. The 
restriction enzymes used included HindIII, EcoRI-HF, XbaI, and KpnI-HF. pUBI-attB 
was used as the plasmid vector, and mouse VDAC 2 were used as the insert. In a 1.5 mL 
tube, 1 µL of DNA, 1 µL of an appropriate restriction enzyme, 2 µL of CutSmart Buffer, 
and 16 µL of H2O were added together. The tube was then incubated in 37°C for 30 
minutes. Finally, a gel electrophoresis was then performed to visualize the results of the 
digest. 
 
2.2: Gel Electrophoresis  
 Gel electrophoresis was used as a standard lab procedure for separating DNA by 
size for visualization and purification. An electric field was used to move the negatively 
charged DNA down an agarose gel towards the positive electrode. Shorter DNA 
fragments were able to migrate further down the agarose gel than larger ones. The 
estimated length of DNA fragments were found by comparing them to a 1 Kb DNA
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ladder. The gel electrophoresis was performed using an electrophoresis chamber, voltage 
source, prepared sample, TAE buffer, agarose, and ethidium bromide. A 0.8% 
concentration of agarose gel was measured using 15 mL TAE buffer, 60 mL of 1% 
agarose solution, and 0.75 µL of 10mg/mL ethidium bromide solution. The agarose gel 
was poured into the chamber with a well comb in place, and this was left to harden for 20 
minutes. 4 µL of 6x loading buffer was added to the prepared sample for visualization. 10 
µL of 1 Kb ladder was loaded in the first well, with the prepared samples in the following 
wells. The gel was left to run for 30 minutes at 120 V. Finally, a gel documentation 
device with a UV light box and camera was used to visualize the DNA bands in the gel. 
 
2.3: Ligation  
 Ligations were performed to join two DNA fragments using an enzyme. The 
plasmid was constructed by connecting the insert DNA into the digested vector 
backbone. T4 DNA ligase enzyme was used to carry out the reaction. The DNA ligase 
catalyzed covalent phosphodiester bonds to join the nucleotides together. The restriction 
digests created overhangs, also known as "sticky end," in the DNA samples. The sticky 
ends in the vector and insert were compatible, allowing them to bind together in the 
ligation reaction. Two different enzymes were used to ensure that the insert would bind in 
the correct orientation and to keep the vector from binding to itself. Controls were also 
carried out to check for complete digestion. In a 1.5 mL tube, 0.5 µL of pUBI-attB 
vector, 0.5 µL of VDAC2 insert, 1 µL of T4 DNA ligase enzyme, 1 µL of T4 10x ligase 
buffer, and 7 µL of H2O were added together. For the first control sample, 0.5 µL of 
pUBI-attB vector, 1 µL of T4 DNA ligase enzyme, 1 µL of T4 10x ligase buffer, and 7.5 
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µL of H2O were added together in a 1.5 mL tube. Also, for the second control sample, 0.5 
µL of VDAC2 insert, 1 µL of T4 DNA ligase enzyme, 1 µL of T4 10x ligase buffer, and 
7.5 µL of H2O were added together in a 1.5 mL tube. The tubes were then incubated at 
18°C overnight.  
 
2.4: Transformation  
 Transformations were conducted to introduce foreign DNA into a cell. First, 
competent cells were taken out of the freezer and put on ice to thaw. A LB agar plate 
containing the appropriate antibiotic was placed at 37°C to warm. 1 µL of the sample 
from the ligation along with 25 µL of max efficiency cells were mixed in a 1.5 mL tube. 
The mixture was then left on ice for 30 minutes. Next, the sample was heat shocked for 
30 seconds at 42°C. Then 250 µL of SOC media was added to the tube. The tube was 
then placed in a shaking incubator for 1 hour at 37°C. Finally, 25 µL of the sample was 
plated on the LB algar plate and incubated at 37°C overnight. 
 
2.5: Plasmid DNA Minipreps  
 Alkaline lysis was performed to isolate the circular plasmid DNA from bacterial 
cells. First, 2 mL cultures from single colonies of bacteria that contained the plasmid 
DNA was grown overnight. 1.5 mL of the culture was then poured into a centrifuge tube. 
The tube was then centrifuged in a microfuge to pellet the cells, and the supernatant was 
removed. The bacterial pellet was resuspended in 100 µL of Solution 1 and vortexed 
vigorously. Solution 1 consisted of 25 mM Tris-HCl (pH 8). 200 µL of Solution 2, the P2 
Buffer, was then added. The P2 buffer consisted of 0.2 N NaOH and 1.0% SDS. The
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contents of the tube were mixed by inverting the tube quickly five times. The tube sat on 
ice for 5 minutes Then, 150 µL of ice-cold Solution 3, Potassium Acetate, was added, and 
the tube was gently vortexed for 10 seconds. The tube was then centrifuged at 12,000g 
for 5 minutes at 4°C in a microfuge. The supernatant was removed, and the tube sat in an 
inverted position to ensure all fluid drained away. The pellet was then rinsed with 150 µL 
of 70% ethanol at 4°C, and the supernatant was removed again. Finally, the DNA was 









 To construct transgenic DNA plasmids containing mouse VDAC2 and Bax 
cDNAs, we first selected a plasmid vector for experimentation. As seen in Figure 6, 
Jones designed a plasmid map for the pUBI-attB plasmid.  
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Figure 6: Plasmid map of the pUBI-attB vector. The blue region from about 4900 bp 
to 6800 bp represents the ubiquitin genomic promoter region. The attB recognition site is 
in royal blue around 7,600 bp (Adapted from Jones, 2019). 
 
Then, we could use this map to determine which restriction enzymes to use and 
visualize the lengths of resulting fragments (Figure 6). pUBI-attB was selected as the 
proper plasmid vector for experimentation due to its ubiquitin (UBI) genomic promoter 
region and its attB recognition site. These elements were necessary because the VDAC2 
gene could not be expressed in Drosophila melanogaster without them. Ubiquitin is a 
protein that is expressed in all Drosophila melanogaster tissues. A DNA sequence 
inserted into the plasmid after this region will be turned on in all cells. Also, a plasmid 
with an attB recognition site was chosen because we use a Drosophila melanogaster line 
that expresses phiC31 integrase as well as having an attP site on chromosome 3. This 
integrase mediates site-specific recombination between its attB and attP recognition sites 
(Groth, Amy C., et al., 2004). It functions to promote the integration of an attB-
containing plasmid into the attP site, creating transgenic offspring (Groth, Amy C., et al., 
2004). 
The first step in constructing the transgenic plasmids was performing three 
different restriction digests using various restriction enzymes to confirm the restriction 
sites of the plasmid. I began by digesting 1 µL of pUBI-attB with 2 µL of Cutsmart 
buffer, 1 µL of BamHI restriction enzyme, and 16 µL of H2O (Figure 7). I repeated this 
process by digesting 1 µL of pUBI-attB with 2 µL of Cutsmart buffer, 1 µL of XhoI 
restriction enzyme, and 16 µL of H2O and by digesting 1 µL of pUBI-attB with 2 µL of 
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Cutsmart buffer, 1 µL of EcoRI restriction enzyme, 1 µL of HindIII restriction enzyme, 
and 15 µL of H2O (Figure 7). The resulting fragments in Figure 7 matched with the 
predicted lengths gathered from Figure 6.  
 
Figure 7: Agarose gel from restriction digest of pUBI-attB. The first lane contains 10 
µL of a 50 bp ladder. Lane 1 contains 1 µL of pUBI-attB cut using 1 µL of BamHI 
restriction enzyme. Lane 2 contains 1 µL of pUBI-attB cut using 1 µL of XhoI restriction 
enzyme. Finally, Lane 3 contains 1 µL of pUBI-attB cut using 1 µL of EcoRI restriction 
enzyme and 1 µL of HindIII restriction enzyme. 
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Next, Jones designed a map for the mouse VDAC2 cDNA insert, as seen in 
Figure 8. This map was used to determine which restriction enzymes to use and visualize 
the lengths of resulting fragments.  
 
Figure 8: Map of mouse VDAC2 cDNA insert. (Adapted from Jones, 2019). 
 
 After analyzing the map of the mouse VDAC2 cDNA insert, we decided to 
perform a restriction digest on the insert. I first digested 2 µL of DNA insert with 2 µL of 
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Cutsmart buffer, 1 µL of EcoRI-HF restriction enzyme, 1 µL of XbaI restriction enzyme, 
and 14 µL of H2O (Figure 9). I also digested 2 µL of DNA insert with 2 µL of Cutsmart 
buffer, 1 µL of KpnI restriction enzyme, and 15 µL of H2O (Figure 9). 
 
Figure 9: Agarose gel from restriction digest of VDAC2 insert. The first lane contains 
10 µL of a 50 bp ladder. Lane 1 contains 2 µL of mouse VDAC2 cDNA insert cut with 1 
µL of EcoRI-HF restriction enzyme and 1 µL of XbaI restriction enzyme. Lane 2 
contains 2 µL of mouse VDAC2 cDNA insert cut with 1 µL of KpnI restriction enzyme.  
 
 Furthermore, Jones constructed a third plasmid map that represented the 
transgenic plasmid consisting of pUBI-VDAC2-attB (Figure 10). This figure was used to 
understand the resulting transgenic plasmid from our experiments. 
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Figure 10: Plasmid map of the pUBI-VDAC2-attB. (Adapted from Jones, 2019). 
 
The next step was to purify the fragments of DNA from the previous restriction 
digests. Purifying the vector and insert resulted in fragments seen in Figure 11. The size 
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of the vector fragment was about 10 Kb, and the size of the insert fragment was about 1.4 
Kb (Figure 11). These measurements match the predicted measurements made from 
analyzing the plasmid map of the pUBI-VDAC2-attB (Figure 10). 
 
Figure 11: Agarose gel of purified vector and insert. The first lane contains 10 µL of a 
1 Kb ladder. Lane 1 contains 1 µL of purified pUBI-attB vector, and Lane 2 contains 1 
µL of purified VDAC2 cDNA insert.  
 
 Ligations were then performed to join the two DNA fragments using an enzyme. 
The transgenic plasmid was constructed by connecting the insert DNA into the digested 
vector backbone. T4 DNA ligase enzyme was used to carry out the reaction. The DNA 
ligase catalyzed covalent phosphodiester bonds to form to join the nucleotides together. 
Controls were also performed to check for complete ligation. Transformations on a LB 
agar plate containing the appropriate antibiotic were also conducted to introduce foreign 
DNA into a cell. The agar plates incubated at 37°C overnight.
18 
Plasmid DNA Minipreps were then performed to isolate the circular transgenic 
plasmid DNA from bacterial cells. Figure 12 shows a restriction digest of the Minipreps 
and that the plasmid DNA was successfully isolated from the bacterial cells.  
 
Figure 12: Plasmid DNA Mini preps of pUBI -VDAC2-attB. The first lane contains 10 
µL of a 1 Kb ladder. Lanes 1-6 contains 5 µL of DNA, 2 µL of Cutsmart buffer, 1 µL of 
EcoRI restriction enzyme, 1 µL of XbaI restriction enzyme, and 11 µL of H2O (Adapted 
from Jones, 2019). 
 
Finally, a restriction digest was performed on the resulting DNA using 1 µL of 
pUBI-VDAC2-attB, 2 µL of Cutsmart buffer, 1 µL of EcoRI restriction enzyme, 1 µL of 
XbaI restriction enzyme, and 15 µL of H2O (Figure 13). I then performed a DNA gel 
extraction to isolate the desired DNA.  
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Figure 13: Agarose gel from restriction digest of pUBI-VDAC2-attB. The first lane 
contains 10 µL of a 1 Kb ladder. Lanes 1 contains 1 µL of pUBI-VDAC2-attB, 2 µL of 
Cutsmart buffer, 1 µL of EcoRI restriction enzyme, 1 µL of XbaI restriction enzyme, and 






















The results obtained can now be used to create the transgenic lines of Drosophila 
melanogaster. Dr. Jones is currently injecting the pUBI-VDAC2-attB plasmids into 
hundreds of Drosophila melanogaster embryos and integrating it into their genomes. Dr. 
Jones has obtained one line that has the pUBI-VDAC2-attB plasmid integrated. Lines 
that have the pUBI-VDAC2-attB plasmid integrated express an altered red eye phenotype 
compared to the other lines that have white eyes.  
We hope to further experimentation by crossing this transgenic line with other 
lines such as UAS-Bax to examine the phenotypic effect. Once these lines have been 
crossed, the offspring can be crossed with a line of GMR-Gal4 that will turn on the Bax 
gene in the eye. The flies containing the pUBI-VDAC2-attB transgene can then be 
compared to those lacking this alteration.  
The goal is to determine whether this genetic change leads to a beneficial or 
harmful phenotypic morphology in the flies. We predict that expressing VDAC2 in the 
eye or wing will restrain Bax, making Bax less potent, and therefore cause a less harmful 
phenotypic morphology. On the otherhand, expressing VDAC2 could cause Bax to 
become more potent, leading to a more damaging phenotypic morphology. It could also 
cause no phenotypic change in the flies. The interruption of the academic calendar due to 
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